Drug intelligence / Profile preview

5-methyl-2'-deoxypseudouridine

Development stage
Unknown
Modality
Small Molecules
01

Overview

5-methyl-2'-deoxypseudouridine is a synthetic nucleoside analog structurally related to pseudouridine and thymidine. It features a methyl group at the C5 position and a deoxy modification at the ribose sugar, making it distinct from naturally occurring uridines. This compound is classified as an experimental small molecule and has not been approved for clinical use. Its primary research application is as a substrate or ligand in studies of nucleoside metabolism, particularly involving nucleoside 2-deoxyribosyltransferase enzymes, which play roles in nucleotide salvage pathways. The compound may be used to investigate enzyme specificity, catalysis mechanisms, or as an intermediate in the synthesis of modified oligonucleotides for biochemical research[1][3][4][5]. No therapeutic mechanism of action or clinical indication has been established.

Other names
5-methyl-2'-deoxypseudouridinepseudothymidine2'-deoxy-1-methyl-pseudouridine65358-15-8 (CAS number)
02

Targets

NDT (Nucleoside 2-deoxyribosyltransferase)

Beyond the preview

Go deeper on 5-methyl-2'-deoxypseudouridine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-methyl-2'-deoxypseudouridine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call